Dr. Chen Sihan, a plastic surgeon at Chengda Hospital, said that the proportion of hemangioma in white infants is quite high, with infants before 1 0 ~12%; Taiwan Province Province is even less, and the incidence rate is about 1 ~ 2.6%. However, if the number of newborns in Taiwan Province Province is about166,000 in 2065, about 2,000 people will suffer from hemangioma in 438+00.
Infantile hemangioma is mainly caused by abnormal proliferation of vascular endothelial cells, and its etiology is still unclear. According to its development and change, it can be roughly divided into three stages:
Proliferative stage: Hemangiomas that appear after birth proliferate very quickly and often grow faster than babies. It usually continues to proliferate for 8 months.
Stable period: after the baby 1 year, the hemangioma stops growing.
Degenerative stage: Hemangiomas will gradually degenerate and atrophy around 2 years old.
Chen Sihan pointed out that according to the long-term experience of domestic medical circles in treating hemangioma, if the patient still shows no signs of degeneration at the age of 2, the hemangioma should not degenerate, accounting for about 20-30% of all hemangioma patients. Children who still have hemangioma will cause uneven skin color, skin atrophy or scar tissue.
Hemangiomas will immediately enter the proliferative phase 2 ~ 3 weeks after birth, and treatment should be started as soon as possible at this stage to prevent further proliferation. There are many methods to treat infantile hemangioma. According to the different changes of hemangioma, Dr. Chen Sihan established a trilogy of treatment:
The first song-drug therapy: the sick child was diagnosed as hemangioma 8 months before birth, and took B- sympathetic nerve blocker orally, in combination with breast milk or breast milk. According to a large-scale study in the international medical field, oral B-type sympathetic nerve blockers are safe for infants with hemangioma, and only a few users will have side effects such as slow heartbeat, decreased blood pressure, bronchospasm and insufficient blood sugar concentration.
Two-part injection therapy: the hemangioma of the sick child is still hypertrophy and bulging after 8 months. Local injection of vascular sclerosing agent can destroy endothelial cells in hemangioma and produce saponification reaction, so as to flatten hemangioma.
Trilogy-Laser Therapy: After 65,438+0 years old, the patients were followed up for hemangioma. If the focus is only residual color without hypertrophy, laser treatment will be suggested to remove the color of the focus and achieve the effect of completely eliminating hemangioma.
Chen Sihan reminded parents that for the treatment of infantile hemangioma, we need to find a specialist for full discussion and careful evaluation before treatment, and we also need full support and patience. I believe my baby can say goodbye to strawberries smoothly.
Chen Sihan, plastic surgeon, Chengda Hospital. Figure/Chengda provides that infantile hemangioma usually occurs in the neck of female voice. Figure/Chengda provides that infantile hemangioma usually occurs in the neck of female voice. Figure/Chengda provided